Synopsis:
Three micro-cap stocks gained attention after securing new contracts, boosting growth prospects. Agarwal Toughened Glass India, Cryogenic OGS, and Shelter Pharma won fresh orders across various sectors.
Several micro-cap companies have recently attracted investor attention after announcing fresh work orders that could significantly boost their revenue visibility and market standing. These developments highlight growing business momentum and potential turnaround opportunities within this cap segment. Here’s a closer look at three such micro-cap stocks now in focus following their latest contract wins.
Here is the list of Micro-cap Stocks with new orders
Agarwal Toughened Glass India Ltd
Agarwal Toughened Glass India Ltd. is a Jaipur-based company that manufactures and processes various types of glass, including toughened, laminated, frosted, and insulated glass. Established in 2009, the company serves the construction, automotive, and industrial sectors with its safety and strength-focused products. It holds ISO 9001:2015 certification and adheres to Indian and international quality standards.
With a market capitalization of Rs. 243.29 crores on Thursday, the shares of Agarwal Toughened Glass India Ltd jumped upto 1.45 percent, making a high of Rs. 139.00 per share compared to its previous closing price of Rs. 137.00 per share.
Agarwal Toughened Glass India Limited has received multiple purchase orders from domestic entities, totaling around Rs. 2.5 crores (₹25 million). These orders are for the supply of Double Glazed Units (DGU) value-added glasses for hospital and commercial mall projects. The orders, which amount to approximately 6,790 SQM of glass, are scheduled to be completed by March 2026.
Cryogenic OGS Ltd
Cryogenic OGS Ltd is an engineering company based in Vadodara, Gujarat, that manufactures high-quality measurement and filtration equipment for the oil, gas, and chemical industries. Founded in 1997, the company specializes in customized solutions, including products like basket strainers, air eliminators, and prover tanks, and also offers design, fabrication, and testing services.
With a market capitalization of Rs. 241.26 crores on Thursday, the shares of Cryogenic OGS Ltd hit a 5 percent lower circuit, making a low of Rs. 206.15 per share compared to its previous closing price of Rs. 217.00 per share.
Cryogenic OGS Limited (formerly Cryogenic Liquide Private Limited) has received a Letter of Intent (LOI) from Suzlon Western India Projects Limited for the manufacture and supply of Tower and Nacelle Jigs. The total value of the order is Rs. 1.08 crores (₹1,07,89,040), with two separate contracts of Rs. 39.8 lakh and Rs. 68.1 lakh. The orders, which will be executed within 4 to 6 weeks, are awarded by a domestic entity. The contracts involve the manufacture and supply of Tower and Nacelle Jigs, with an expected delivery timeline of 4 to 6 weeks.
Shelter Pharma Limited
Shelter Pharma Limited is a 59-year-old Indian pharmaceutical company, based in Gujarat, that specializes in manufacturing natural Ayurvedic and Unani remedies for human and animal health. The company was founded in 1965 and has a diverse product portfolio of over 300 formulations, with a strong presence in both rural and semi-urban markets.
With a market capitalization of Rs. 48.32 crores on Thursday, the shares of Shelter Pharma Limited jumped upto 0.7 percent, reaching a high of Rs. 41.80 per share compared to its previous closing price of Rs. 41.50 per share.
Shelter Pharma Limited has secured an international order worth $98,875 (Rs. 0.82 crores) from Taha Drugs & Chemicals Co. Ltd, based in Sudan. The order is for Joemega Capsules and all Vitamin Tablets, with a fixed cost contract to be executed within 2 months.
Written By Sridhar J
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
